Wells Fargo raises Hinge Health price target to $90
Wells Fargo analyst Stan Berenshteyn maintains an Overweight rating on Hinge Health (NYSE: HNGE) and raises the price target from $80 to $90, signaling confidence in the company's growth prospects.
*this image is generated using AI for illustrative purposes only.
Wells Fargo analyst Stan Berenshteyn has maintained an Overweight rating on Hinge Health (NYSE: HNGE) and raised the price target to $90, up from the previous $80. The revised target reflects increased confidence in the company's market position and growth trajectory.
Rating and Price Target Update
The decision to upgrade the price target comes as Hinge Health continues to execute on its strategic initiatives. The Overweight rating suggests that the stock is expected to outperform the broader market in the near term.
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $80 |
| New Price Target | $90 |
Analyst Outlook
Berenshteyn's revised valuation underscores the potential for sustained growth. The new price target of $90 represents a significant upside from the prior target of $80, indicating a bullish outlook on the stock's performance.
What specific strategic initiatives are driving the increased confidence in Hinge Health's market position?
How might competitors respond to Hinge Health's projected growth trajectory?
What are the potential risks that could hinder Hinge Health from reaching the $90 price target?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
